Skip to main content

Mass General Brigham, Inc

SEC CIK
0001678378
Latest filing
Aug 7, 2026

FULC holding history

Fulcrum Therapeutics, Inc. in every 13F filed by Mass General Brigham, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FULC overviewAll 13F holders of FULCFull Q2 2026 holdings

Shares (Q3 2024)
205,356
Value
$733.1K
% of portfolio
1.7%
Quarters held
4
Since Q3 2021
Holdings of FULC by Mass General Brigham, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2024––––Not filedHolders
Q3 2024205,356$733.1K1.7%00.0%UnchangedHolders
Q2 2024205,356$1.27M6.2%00.0%UnchangedHolders
Q1 2024205,356$1.94M3.4%+205,356NewHolders
Q4 20210$00.0%−15,860−100.0%Sold outHolders
Q3 202115,860$447.0K0.1%+15,860NewHolders